MedPath

European Lung Cancer Working Party

🇧🇪Belgium
Ownership
-
Employees
-
Market Cap
-
Website

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

Phase 2
Completed
Conditions
Malignant Mesothelioma
Interventions
First Posted Date
2008-03-12
Last Posted Date
2015-02-12
Lead Sponsor
European Lung Cancer Working Party
Target Recruit Count
45
Registration Number
NCT00634205
Locations
🇧🇪

Department of Pneumology Hôpital Ixelles-Molière, Brussels, Belgium

🇧🇪

Department of Pneumology Hôpital Saint-Joseph, Gilly, Belgium

🇧🇪

Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels, Belgium

and more 5 locations

Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer

Phase 3
Completed
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
Drug: Cisplatin, Ifosfamide, Gemcitabine
Drug: Ifosfamide, Gemcitabine
First Posted Date
2008-02-25
Last Posted Date
2013-01-30
Lead Sponsor
European Lung Cancer Working Party
Target Recruit Count
707
Registration Number
NCT00622349
Locations
🇬🇷

Hellenic Cancer Institute - St Savas Oncology Hospital, Athens, Greece

🇧🇪

Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels, Belgium

🇫🇷

Pneumology department of CHU Lille, Lille, France

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath